Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Abiraterone acetate (Primary) ; Dasatinib (Primary) ; Sunitinib (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 21 Sep 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 21 Sep 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov record.